Serum von Willebrand Factor and Thymic Stromal Lymphopoietin Levels Are Associated With Asthma Predictive Index in Preschool Children With Recurrent Wheezing
Related Experiment Video
Updated: Aug 21, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
E Mancino1, R Nenna1, L Petrarca1
1Department of Maternal Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.
Insights
Biomarkers thymic stromal lymphopoietin (TSLP) and von Willebrand factor (vWF) may improve asthma prediction in children with recurrent wheezing. Elevated levels of TSLP and vWF were associated with a positive Asthma Predictive Index (API) score.
Area of Science:
- Pediatric Pulmonology
- Biomarker Discovery
- Asthma Research
Background:
- Recurrent wheezing affects many preschoolers, with a third developing asthma.
- Early risk stratification for asthma is crucial for timely intervention.
- The Asthma Predictive Index (API) aids in risk assessment, but its accuracy can be enhanced.
Purpose of the Study:
- To investigate the potential of biological markers, specifically thymic stromal lymphopoietin (TSLP) and von Willebrand factor (vWF), in improving asthma risk prediction.
- To assess the association between TSLP and vWF levels and the Asthma Predictive Index (API) in children with recurrent wheezing.
Main Methods:
- A prospective cohort study enrolled 92 children aged 1-5 years with recurrent wheezing.
- The Asthma Predictive Index (API) was used to classify children into API-positive and API-negative groups.
- Blood samples were analyzed for complete blood count, total Immunoglobulin E, TSLP, and vWF levels.
Main Results:
- TSLP and vWF levels were significantly higher in API-positive children compared to API-negative children (p=0.045 for TSLP, p=0.012 for vWF).
- Multivariable analysis confirmed that elevated TSLP and vWF were independently associated with API positivity.
- Median TSLP was 0.473 fg/mL and median vWF was 107.4% in the study cohort.
Conclusions:
- Findings suggest a potential association between vWF, TSLP, and API status in predicting asthma risk.
- Further longitudinal studies are necessary to validate the predictive value of these biomarkers for future asthma development.
- TSLP and vWF may serve as valuable adjuncts to the API for early asthma risk stratification.
Aim:
Recurrent wheezing is a very common condition among preschool children. One third of these patients will develop asthma. Early risk stratification is essential. This can be done through a standardized clinical index, the Asthma Predictive Index (API), but its predictive accuracy may be improved through the integration of biological markers.
Methods:
We conducted a prospective cohort study, enrolling children aged 1 to 5 years with recurrent wheezing. The API was calculated to classify participants as API-positive (Group 1) or API-negative (Group 0). Blood samples were collected in order to perform a complete blood count and measurement of total Immunoglobulin E, thymic stromal lymphopoietin (TSLP) and von Willebrand factor (vWF) levels.
Results:
The study included 92 children. The median TSLP level was 0.473 fg/mL and the median vWF level was 107.4%. According to the API, 74 were API-positive and 18 API-negative. TSLP (0.48 vs. 0.39 fg/mL; p = 0.045) and vWF levels (111.6% vs. 91.7%; p = 0.012) were significantly higher in API-positive children. In multivariable analysis, elevated TSLP and vWF levels were independently associated with API positivity.
Conclusions:
These findings suggest an association between vWF, TSLP, and API status; however, longitudinal studies are required to determine their value in predicting future asthma development.
Related Concept Videos
Asthma I: Introduction
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

